The Centers for Disease Control and Prevention’s Division of HIV Prevention are a critical source of funding and outreach for states, according to Terri L. Wilder, MSW, HIV/Aging Policy Advocate at SAGE, an organization that serves LGBTQ+ elders.
Approximately 10,000 jobs will be cut within the United States Department of Health and Human Services (HHS), according to an HHS news release posted yesterday. The Centers for Disease Control and Prevention’s (CDC) Division of HIV Prevention will likely feel the effects of the cuts, which would impact HIV prevention and care, according to Terri L. Wilder, MSW, an HIV/aging policy advocate at the elder LGBTQ+ organization SAGE.
Wilder recently spoke with Managed Healthcare Executive and explained the types of services the CDC division currently funds and how the cut will impact healthcare.
Terri L. Wilder, MSW
“In a nutshell, it's a disaster,” Wilder said. “This CDC HIV prevention money is really critical, because a lot of the money goes through states’ departments of health that then release it out to the community.”
Wilder went on to explain that these cuts aren’t just a threat to public health programs but to the country’s economy as well.
“If we don't look at it from a public health lens, then maybe people could look at it through an economic lens,” Wilder said. “When a person is diagnosed with HIV, it's an over $500,000 cost in lifetime treatment, so prevention saves money; it saves lives. For me, that's the bottom line for me, is that it saves lives, but think about the cost to our country. Think about the cost to our fragile healthcare system.”
Approximately 27,900 HIV infections were prevented between 2012 and 2022, resulting in an estimated $15.1 billion saved in lifetime medical costs, according to data from the Division of HIV Prevention Federal AIDS Policy Partnership meeting in 2024.
FDA Accepts NDA for Gilead's New HIV Prevention Shot
February 18th 2025Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving this drug a priority review and expects to make a decision by June 19, 2025, according to a release.
Read More
HIV + Hepatitis Institute Welcomes RFK, Talks Importance of Ending the HIV Epidemic
February 13th 2025The group released a statement today expressing that they are eager to work with Robert F. Kennedy Jr. to eradicate HIV when steps into his role as the Secretary of Health and Human Services.
Read More